Physician

Andrew Philip Hampshire, M.D.

According to 2025 Medicare claims, Andrew Hampshire, M.D. (NPI: 1073559068) practices hematology in the San Diego-Chula Vista-Carlsbad, CA market, with the plurality of this provider's patient population coming from San Diego, CA. This provider's primary affiliated billing organization is REGENTS OF THE UNIVERSITY OF CALIFORNIA (NPI: 1508968751; TIN: 237064656) and primary practice location at 92037-0998. Hampshire is affiliated with the Sharp Rees-Stealy Medical Group (ACO ID: A5521), participating under the MSSP model.

Hampshire's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 170 traditional Medicare patients, billed 5,787 HCPCS/CPT codes, and received $243,713 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 1,111 prescription claims across 180 beneficiaries totaling $3,588,788 in drug costs, led by Imbruvica (Ibrutinib). 2017 DME data shows 62 claims. Open Payments data shows 35 records totaling $76,372. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $58,408 to $243,713. Similarly, Part D prescription costs have moved sharply higher in recent years, from $1,422,085 to $3,588,788. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.